Synonyms: EBL-1003 | EL-857 | EL857 | nebramycin factor 2 | nebramycin II
Compound class:
Natural product
|
|
References |
1. Almabruk KH, Chang JH, Mahmud T. (2016)
Total Synthesis of (±)-Isoperbergins and Correction of the Chemical Structure of Perbergin. J Nat Prod, 79 (9): 2391-6. [PMID:27588436] |
2. Kang AD, Smith KP, Eliopoulos GM, Berg AH, McCoy C, Kirby JE. (2017)
Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Diagn Microbiol Infect Dis, 88 (2): 188-191. [PMID:28341099] |
3. Roch M, Sierra R, Sands K, Martins WMBS, Schrenzel J, Walsh TR, Gales AC, Andrey DO. (2021)
Vertical and horizontal dissemination of an IncC plasmid harbouring rmtB 16S rRNA methylase gene, conferring resistance to plazomicin, among invasive ST258 and ST16 KPC-producing Klebsiella pneumoniae. J Glob Antimicrob Resist, 24: 183-189. [PMID:33373732] |
4. Sheng Y, Lam PW, Shahab S, Santosa DA, Proteau PJ, Zabriskie TM, Mahmud T. (2015)
Identification of Elaiophylin Skeletal Variants from the Indonesian Streptomyces sp. ICBB 9297. J Nat Prod, 78 (11): 2768-75. [PMID:26510047] |
5.
Juvabis Announces Positive Phase 1 Results of EBL-1003 in the Innovative Medicines Initiative’s ENABLE Consortium.
Accessed on 23/02/2023. Modified on 23/02/2023. AMR Conference, https://amr-conference.com/news/juvabis-announces-positive-phase-1-results-of-ebl-1003-in-the-innovative-medicines-initiatives-enable-consortium/ |